Modeling and Simulation - PK/PD Archives | Page 4 of 46

On-Demand Webinar

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Watch to see how Phoenix TFL Studio and AI PK Reports automate the final stages…

CertaraFebruary 12, 2026

Blog

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…

CertaraFebruary 11, 2026

Live Events

Phoenix Roadshow 2026 – Florence

CertaraFebruary 2, 2026

Publication

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…

CertaraFebruary 2, 2026

On-Demand Webinar

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…

CertaraJanuary 30, 2026

On-Demand Webinar

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

This on demand session demonstrates how Phoenix WinNonlin® and other tools work together within Phoenix®…

CertaraJanuary 27, 2026

Conference

Quantitative Systems Pharmacology Conference

CertaraJanuary 26, 2026

Blog

How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most

Learn how Model-Informed Drug Development strengthens drug asset valuation by reducing uncertainty, predicting clinical performance,…

CertaraJanuary 26, 2026

Webinar

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Danielle PillsburyJanuary 22, 2026

Webinar

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

CertaraJanuary 22, 2026

Modeling and Simulation – PK/PD

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

Phoenix Roadshow 2026 – Florence

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

Quantitative Systems Pharmacology Conference

How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

Newsletter sign up

Quick links

Solutions

Contact